Anastasios Raptis

2.0k total citations
50 papers, 994 citations indexed

About

Anastasios Raptis is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Anastasios Raptis has authored 50 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 20 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Anastasios Raptis's work include Acute Myeloid Leukemia Research (22 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Multiple Myeloma Research and Treatments (13 papers). Anastasios Raptis is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Multiple Myeloma Research and Treatments (13 papers). Anastasios Raptis collaborates with scholars based in United States, France and Italy. Anastasios Raptis's co-authors include Jeffrey J. Molldrem, A. John Barrett, Michael Boyiadzis, Dimitriοs Mavroudis, Nancy F. Hensel, Emmanuel Clave, Mounzer Agha, Yin Jiang, Jing‐Zhou Hou and Robert L. Redner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Anastasios Raptis

47 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anastasios Raptis United States	15	465	383	352	280	185	50	994
Nicolás Novitzky South Africa	20	821 1.8×	468 1.2×	339 1.0×	325 1.2×	180 1.0×	65	1.3k
Toshiki Yamada Japan	18	441 0.9×	274 0.7×	336 1.0×	249 0.9×	135 0.7×	61	1.1k
Yeo‐Kyeoung Kim South Korea	20	675 1.5×	243 0.6×	261 0.7×	253 0.9×	412 2.2×	91	1.2k
Vladan Vučinić Germany	18	518 1.1×	230 0.6×	333 0.9×	153 0.5×	177 1.0×	105	934
Zaid Al‐Kadhimi United States	18	425 0.9×	337 0.9×	540 1.5×	108 0.4×	182 1.0×	84	1.0k
Paul Cannell Australia	18	519 1.1×	183 0.5×	373 1.1×	251 0.9×	229 1.2×	55	1.1k
Jing‐Zhou Hou United States	14	367 0.8×	503 1.3×	332 0.9×	115 0.4×	232 1.3×	59	967
Ohad Benjamini Israel	15	247 0.5×	199 0.5×	274 0.8×	392 1.4×	178 1.0×	56	920
Monic J. Stuart United States	15	953 2.0×	443 1.2×	431 1.2×	456 1.6×	179 1.0×	26	1.5k
J. L. Harousseau France	14	436 0.9×	133 0.3×	293 0.8×	163 0.6×	199 1.1×	35	812

Countries citing papers authored by Anastasios Raptis

Since Specialization

Citations

This map shows the geographic impact of Anastasios Raptis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anastasios Raptis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anastasios Raptis more than expected).

Fields of papers citing papers by Anastasios Raptis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anastasios Raptis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anastasios Raptis. The network helps show where Anastasios Raptis may publish in the future.

Co-authorship network of co-authors of Anastasios Raptis

This figure shows the co-authorship network connecting the top 25 collaborators of Anastasios Raptis. A scholar is included among the top collaborators of Anastasios Raptis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anastasios Raptis. Anastasios Raptis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Im, Annie, Kevin Quann, Mounzer Agha, et al.. (2024). Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients. American Journal of Hematology. 99(3). 380–386. 1 indexed citations

Posluszny, Donna M., Dana H. Bovbjerg, Karen L. Syrjala, et al.. (2021). Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers. Transplantation and Cellular Therapy. 28(3). 165.e1–165.e9. 10 indexed citations

Mateos, María‐Victoria, Albert Oriol, Alessandra Larocca, et al.. (2020). HORIZON (OP-106): An exploratory analysis of time-to-next treatment (TTNT) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) who received melflufen plus dexamethasone (dex).. Journal of Clinical Oncology. 38(15_suppl). e20570–e20570. 4 indexed citations

Redner, Robert L., Jan H. Beumer, Patricia Kropf, et al.. (2018). A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia. Leukemia & lymphoma. 59(11). 2595–2601. 10 indexed citations

Boyiadzis, Michael, Mounzer Agha, Robert L. Redner, et al.. (2017). Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia. Cytotherapy. 19(10). 1225–1232. 139 indexed citations

Roth, Christine G., David R. Weber, Alison R. Sehgal, et al.. (2016). ICU intervention during induction chemotherapy for adult patients with newly diagnosed acute myeloid leukemia. Leukemia Research. 48. 16–19. 1 indexed citations

Agha, Mounzer, Anastasios Raptis, Jing‐Zhou Hou, et al.. (2016). Leukapheresis in patients newly diagnosed with acute myeloid leukemia. Transfusion and Apheresis Science. 55(2). 216–220. 20 indexed citations

Raptis, Anastasios, Jing‐Zhou Hou, Rafic Farah, et al.. (2015). Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplant. European Journal Of Haematology. 96(1). 55–59. 1 indexed citations

McLaughlin, Brian, Annie Im, Anastasios Raptis, et al.. (2012). Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy. International Journal of Hematology. 96(6). 743–747. 9 indexed citations

10.

Strickland, Stephen A., Anastasios Raptis, James Rutledge, et al.. (2012). Correlation of the microculture-kinetic drug-induced apoptosis assay with patient outcomes in initial treatment of adult acute myelocytic leukemia. Leukemia & lymphoma. 54(3). 528–534. 9 indexed citations

11.

Lieberman, Frank S., Victor Yazbeck, Anastasios Raptis, Raymond E. Felgar, & Michael Boyiadzis. (2011). Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation. Journal of Neuro-Oncology. 107(2). 225–232. 22 indexed citations

12.

Foon, Kenneth A., Robert L. Redner, Anastasios Raptis, et al.. (2011). Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapy. Leukemia Research. 35(7). 885–888. 13 indexed citations

13.

Sehgal, Rajesh, Robert L. Redner, Anastasios Raptis, et al.. (2009). Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin. Leukemia & lymphoma. 50(11). 1848–1853. 5 indexed citations

14.

Ballester, Oscar, et al.. (2004). Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma. Bone Marrow Transplantation. 34(5). 419–423. 6 indexed citations

15.

Berkahn, Leanne, David Simpson, Anastasios Raptis, & Hans-Georg Klingemann. (2002). In Vivo Purging with Rituximab Prior to Collection of Stem Cells for Autologous Transplantation in Chronic Lymphocytic Leukemia. Journal of Hematotherapy & Stem Cell Research. 11(2). 315–320. 9 indexed citations

16.

Reece, Donna, Kenneth A. Foon, E. Randolph Broun, et al.. (2001). Interim Analysis of the Use of the Anti-Idiotype Breast Cancer Vaccine 11D10 (TriAb®) in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer. Clinical Breast Cancer. 2(1). 52–58. 8 indexed citations

17.

Agelaki, Sofia, S. Kakolyris, Ph. Palamidas, et al.. (2001). A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer. Lung Cancer. 34(1). 133–139. 3 indexed citations

18.

Raptis, Anastasios, Dimitriοs Mavroudis, Jeffrey J. Molldrem, et al.. (1999). High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients. Bone Marrow Transplantation. 24(8). 879–883. 58 indexed citations

19.

Raptis, Anastasios, et al.. (1999). Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis. Bone Marrow Transplantation. 24(11). 1259–1260. 19 indexed citations

20.

Read, E.J., Jeffrey J. Molldrem, Anastasios Raptis, et al.. (1998). T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia. Bone Marrow Transplantation. 21(5). 431–440. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact